ABSTRACT
Importance Clostridioides difficile is the most common cause of healthcare-associated infections (HAI) in the US. It is unknown whether universal gown and glove use in intensive care units (ICUs) decreases acquisition of C. difficile.
Objective To assess whether wearing gloves and gowns for all patient contact in the ICU decreases acquisition of C. difficile compared with usual care.
Design, setting, and Participants Secondary analysis of a cluster-randomized trial in 20 medical and surgical ICUs in 20 US hospitals from January 4, 2012, to October 4, 2012.
Interventions After a baseline period, ICUs were randomized to standard practice for glove and gown use vs. the intervention of all healthcare workers being required to wear gloves and gowns for all patient contact and when entering any patient room (contact precautions).
Main outcomes and measures The primary outcome was acquisition of toxigenic C. difficile determined by surveillance cultures collected on admission and discharge from the ICU. Secondary outcomes included ribotype 027-like C. difficile acquisition and the impact of other factors on acquisition.
Results From the 26,749 patients enrolled in the study, a total of 21,845 patients had both admission and discharge perianal swabs cultured for toxigenic C. difficile. On admission, 9.43% (2,060/21,845) of patients were colonized with toxigenic C. difficile. No significant difference was observed in the rate of toxigenic C. difficile acquisition with universal gown and glove use. Differences in acquisition rates in the study period compared to baseline period in control ICUs were 1.49 per 100 patient days vs 1.68 per 100 patient days in universal gown and glove ICUs, (rate difference -0.28, generalized linear mixed model, p=0.091). Similarly, there was no difference in rates of ribotype 027-like C. difficile acquisition: control ICUs 0.13 per 100 patient days vs. 0.16 per 100 patient days in universal gown and glove ICUs during the study period, (rate difference -0.03, generalized linear mixed model, p=0.35). Secondary analyses identified C. difficile colonization was associated with acquisition, p=0.014).
Conclusions and relevance Glove and gown use for all patient contact in medical and surgical ICUs did not result in a reduction in the acquisition of C. difficile compared with usual care.
Question Does wearing gloves and gowns for all patient contact in the ICU decrease acquisition of C. difficile?
Findings Glove and gown use for all patient contact in medical and surgical ICUs did not result in a difference in the acquisition of C. difficile compared with usual care.
Meaning Glove and gown use does not impact acquisition of C. difficile from asymptomatically colonized patients. Universal use of glove and gowns or targeted use based on active surveillance for C. difficile are unlikely to impact transmission.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Grant #1R01HS025456 from the Agency for Healthcare Research and Quality (AHRQ), U.S. Department of Health and Human Services (HHS).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The University of Maryland Baltimore Institutional Review board gave ethical approval for this work.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Trial registration: Clinicaltrials.gov identifier NCT01318213
Data Availability
Limited data produced in the present study are available upon reasonable request to the authors
